The U.S. cannabis industry continues to expand, with over 80% of Americans now supporting some form of legalization. Recent headlines show the DEA is likely to reschedule marijuana from Schedule I to Schedule III. This move could ease tax burdens and promote medical research. Analysts project the legal U.S. cannabis market could surpass $71 billion by 2030. As more states adopt legal programs, smaller companies with growth potential are gaining attention. Therefore, marijuana penny stocks remain attractive to traders looking for high-reward opportunities. However, the sector is still volatile. Investors should combine technical analysis with sound risk management strategies. Look for price support levels, breakout setups, and volume confirmations. Also, use proper stop-loss orders to manage risk. With legalization efforts gaining momentum, short-term spikes are likely. Thus, traders should stay alert this week. Momentum, news catalysts, and chart setups will help identify top entries.

Many catalysts continue to build toward full cannabis legalization in the U.S. The SAFE Banking Act could pass by 2025, providing financial services access to cannabis businesses. Additionally, more states are preparing for ballot initiatives in 2026 and 2028. These changes will likely increase investor interest in cannabis stocks, especially low-priced ones. As the market reacts to legalization news, marijuana penny stocks often show fast moves.

Marijuana Stocks with Rebound Potential

Because of their affordability, these stocks allow exposure with limited capital. However, their volatility requires extra caution. Traders must use chart patterns, moving averages, and volume indicators. Also, focus on entries near support with clear upside targets. Watching for confirmation and avoiding emotional decisions is key. Moreover, stay updated with news developments and legislative updates. As always, use a trade plan with risk parameters in place. This week, several penny stocks are positioned to benefit from current momentum. Let’s review the most promising names now.

As the U.S. cannabis industry gains momentum, investors are eyeing select stocks with growth potential. Federal rescheduling is expected soon, which could reduce operators’ tax burdens and attract institutional capital. The SAFE Banking Act also remains on the table. Meanwhile, consumer demand continues rising in both medical and recreational markets. In this environment, several marijuana companies are positioned for strong performance. The following are three top marijuana stocks to watch in May 2025.

[Read More] Marijuana Market Set to Surge by 2030— Here Are This Week’s Top U.S. Stock Picks

Top Marijuana Stocks to Watch in May 2025

1. Verano Holdings Corp. (OTC: VRNOF)
2. Cansortium Inc. (OTC: CMTNF)
3. Ayr Wellness Inc. (OTC: AYRWF)

Verano Holdings Corp. (VRNOF)

Verano Holdings is a major U.S. multi-state operator with a large retail presence. The company operates over 150 dispensaries nationwide. Florida is its largest market, where it runs more than 80 stores. Verano also has locations in Illinois, New Jersey, and Arizona. The company sells both medical and recreational cannabis under brands like Zen Leaf and MÜV. Its footprint spans 13 states, giving it broad market exposure. This helps Verano adapt to new regulations and consumer demand. The company continues expanding through strategic acquisitions and organic growth. Management has focused on building scale and efficiency across regions. Verano has earned a reputation for premium products and consistent operations. As the industry matures, Verano aims to strengthen its national market share. Its broad retail network provides strong positioning for future U.S. legalization. In May 2025, Verano remains one of the most watched names in cannabis.

Verano’s latest financial results show mixed performance due to market pricing pressure. Quarterly revenue reached $210 million, slightly down from the previous year. Gross profit stood at $100 million, reflecting tighter margins. The company reported an adjusted EBITDA of $54 million. This represented 26% of total revenue, showing stable operating performance. However, the net loss was $12 million, reflecting ongoing challenges. Despite that, Verano produced positive operating cash flow of $2 million. Capital spending totaled $14 million, aimed at upgrading retail facilities. The company remains focused on cutting costs while preserving long-term growth. Verano continues to streamline operations in maturing markets. The balance sheet remains stable, with manageable debt levels. Management expects improved pricing conditions in the second half of 2025. Investors will be watching for signs of margin recovery and stronger cash flow. Overall, Verano remains a solid operator with long-term potential.

[Read More] Top Performing U.S. Marijuana Stocks to Watch in 2025

Cansortium Inc. (CMTNF)

Cansortium Inc. is a U.S.-based cannabis company operating under the Fluent brand. Its largest presence is in Florida, with more than 20 dispensaries. The company is vertically integrated, handling cultivation, processing, and retail. Cansortium serves medical cannabis patients with a wide range of products. These include flower, edibles, oils, and capsules. The company is expanding its geographic footprint through strategic partnerships. It has recently entered new markets to diversify revenue streams. Cansortium has focused on building efficiency at its Florida operations. This includes upgrading cultivation facilities to increase output. The company also continues investing in product innovation. Its dispensaries emphasize education and patient experience. Cansortium’s small-cap status makes it attractive to penny stock investors. It offers exposure to Florida’s large and growing medical market. As regulatory momentum builds, this operator could see increased upside. Cansortium remains a stock to watch closely in May 2025.

Financially, Cansortium is focused on improving profitability. The company generated annual revenue of approximately $104 million. This marks steady growth from the previous year. However, earnings remain under pressure with a negative EPS. The company is actively reducing operating costs and increasing production efficiency. Management is working to expand margins and improve free cash flow. Debt levels are moderate, with upcoming maturities being refinanced. Capital expenditures remain conservative to preserve cash reserves. Cansortium is prioritizing core markets while evaluating potential acquisitions. The company continues investing in cultivation infrastructure. It also maintains adequate liquidity for operational needs. Analysts are watching closely for signs of earnings improvement. Strong sales performance in Florida could support positive surprises. As pricing conditions stabilize, Cansortium may return to profitability. Investors should also monitor its expansion into new states. Overall, the company is progressing toward a stronger financial footing in 2025.

[Read More] Marijuana Stocks To Buy Today And Trade Tomorrow?

Ayr Wellness Inc. (AYRWF)

Ayr Wellness is a vertically integrated cannabis company with operations in several U.S. states. It runs more than 90 licensed dispensaries. Florida is its largest market, followed by Pennsylvania and Massachusetts. Ayr also operates in New Jersey, Nevada, and Illinois. The company continues expanding into Ohio, with several new stores planned. Its brand portfolio includes retail and wellness-based cannabis products. Ayr targets both medical and adult-use customers through tailored offerings. The company focuses on high-quality cultivation and sustainable practices. It invests in staff training, compliance, and patient education. Ayr’s strategic footprint allows access to large and emerging markets. This supports long-term growth as legalization efforts advance. The company has worked to streamline operations and improve efficiency. It aims to be a low-cost producer with premium retail service. Ayr’s footprint, product variety, and operating scale make it a top stock to watch.

Ayr Wellness has taken decisive steps to improve its balance sheet. The company ended 2024 with over $35 million in cash. Operating cash flow reached $9.6 million in the final quarter. Capital expenditures declined to $17.7 million for the year. This helped preserve liquidity and fund core operations. Ayr has focused on cutting debt, reducing interest expenses, and extending maturities. Nearly $400 million in debt was restructured with new terms. Additionally, the company raised new funds through senior note issuance. These moves reduced financial pressure and improved the outlook. Ayr is also focused on revenue growth and margin expansion. New product launches and store openings are expected in 2025. Gross margins remain under pressure but are gradually improving. Ayr’s financial discipline and cost control are key strengths. Investors will be watching for continued revenue growth and stronger profitability. With an improving financial base, Ayr remains well-positioned in the cannabis space.

U.S. Weed Stocks to Track Before the Next Breakout

In conclusion, these three companies—Verano, Cansortium, and Ayr Wellness—stand out for their operational scale and strategic expansion. Each has faced market challenges but continues to position itself for long-term growth. As federal reform efforts progress, these stocks may offer substantial upside. Traders and investors should continue tracking performance, technical levels, and news-driven catalysts in May 2025.

The post Top U.S. Marijuana Stocks to Add to Your Watchlist Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues to expand rapidly as legalization gains momentum nationwide. By 2030, the market is expected to grow to over $76 billion. In 2025 alone, cannabis sales could surpass $35 billion across both medical and recreational markets. Additionally, the industry’s total economic impact may exceed $120 billion when accounting for jobs, taxes, and supply chains. Today, 24 states have legalized adult-use cannabis. Meanwhile, 38 states support medical marijuana programs. This widespread adoption reflects shifting public opinion and policy reform. As demand rises, leading cannabis companies are scaling operations quickly. Investors are watching closely for the next breakout opportunity. This week, several top marijuana stocks are showing strong potential. Their momentum could be fueled by expanding retail networks and strategic market positioning. With the industry on track for long-term growth, timing the right entry is key. Therefore, understanding current technical setups becomes increasingly important.

Legal Cannabis in Focus

As legalization advances, federal rescheduling of cannabis remains a major catalyst. If reclassified, companies could benefit from improved tax treatment and expanded banking access. This change would ease financial burdens and boost long-term profitability. However, risks remain. Regulatory hurdles, local bans, and pricing pressure still impact margins. Therefore, investors must remain cautious and use sound strategies.

Technical analysis can help pinpoint trends and potential reversals. Key indicators such as moving averages, RSI, and volume spikes offer valuable signals. At the same time, proper risk management is essential. This includes setting stop-losses and maintaining position size discipline. Investors should also watch industry news and policy updates closely. These changes can quickly shift market sentiment. As the cannabis space evolves, adaptability and research will remain critical. This week, several U.S.-based stocks stand out due to recent price action and favorable positioning. Tracking their movement may offer strong opportunities in a rapidly growing sector.

As the U.S. cannabis industry continues to expand rapidly, investors are closely watching which companies will benefit most. With projections showing the market reaching tens of billions by 2030, companies with strong infrastructure, broad retail footprints, and healthy balance sheets stand to gain. In May 2025, three standout U.S.-based cannabis companies to watch include Trulieve Cannabis Corp., Curaleaf Holdings, Inc., and Green Thumb Industries Inc. Each company offers unique strengths that position them well for the future.

[Read More] 2025’s Best Cannabis REITs for Building Wealth Over Time

2025 Cannabis Watchlist: U.S. Marijuana Stocks With Big Growth Potential

1. Trulieve Cannabis Corp. (OTC: TCNNF)
2. Curaleaf Holdings, Inc. (OTC: CURLF)
3. Green Thumb Industries Inc. (OTC: GTBIF)

Trulieve Cannabis Corp. (TCNNF)

Trulieve Cannabis Corp. is one of the most established cannabis companies in the United States. It has built a strong reputation for quality and operational efficiency. The company is headquartered in Florida, where it holds a dominant position in the medical marijuana market. Trulieve currently operates more than 180 dispensaries nationwide, most of which are located in Florida, where the company controls nearly half of the market.

Over time, Trulieve has expanded into 11 states, including Pennsylvania and Arizona. This expansion allows it to tap into both medical and adult-use markets. The company follows a vertical integration model. It controls everything from cultivation to distribution, which ensures consistency and cost savings. Trulieve’s focus on operational excellence has helped it build a loyal customer base. Its strong retail footprint and efficient structure make it a key player in the cannabis sector.

Financial Overview

Trulieve reported impressive results in the first quarter of 2025. Revenue increased 12% year-over-year, reaching approximately $298 million. This growth reflects strong consumer demand and efficient scaling efforts. The company’s gross margin stood at 60%, which indicates effective cost control. Adjusted EBITDA came in at $100 million, showcasing solid operational performance.

Trulieve also reported $150 million in cash and equivalents. This healthy cash position gives the company the flexibility to invest in growth. With expanding profit margins and a disciplined financial strategy, Trulieve is positioned for long-term success. It remains a top stock to watch in the cannabis space this month.

[Read More] Top Performing U.S. Marijuana Stocks to Watch in 2025

Curaleaf Holdings, Inc. (CURLF)

Curaleaf Holdings, Inc. is the largest cannabis company in the United States by total revenue. The company is headquartered in New York and operates in 19 states. It runs over 150 retail dispensaries and has 29 cultivation and production facilities. This gives Curaleaf one of the most extensive footprints in the industry.

Curaleaf serves both medical and adult-use customers with a broad range of products. These include cannabis flower, edibles, tinctures, and topicals. Over the past few years, the company has expanded rapidly through multiple strategic acquisitions. These deals have boosted its presence in high-growth markets and enhanced its brand portfolio. Curaleaf’s dedication to innovation and R&D helps it stay ahead of competitors in both product quality and variety.

Financial Overview

In the first quarter of 2025, Curaleaf reported revenue of $420 million. This marks a 15% increase from the same period last year. The company’s gross profit margin rose to 55%, reflecting solid cost control and supply chain efficiency. Adjusted EBITDA reached $110 million, underlining its profitability and strong business execution.

Curaleaf also holds $200 million in cash reserves. This robust financial position supports continued expansion efforts. With increasing sales, healthy margins, and a strong balance sheet, Curaleaf remains well-prepared for future growth. It is a top cannabis stock for investors to keep on their radar in May.

[Read More]  Top Marijuana Stocks In A Volatile Market

Green Thumb Industries Inc. (GTBIF)

Green Thumb Industries Inc. is another major U.S. cannabis company with a growing national presence. Headquartered in Chicago, Green Thumb operates more than 100 dispensaries across 14 states. Most of its retail locations run under the RISE brand, which has gained strong consumer recognition. The company also operates 20 production facilities, allowing for full control of the supply chain.

Green Thumb has created a diverse lineup of product brands. These brands serve both wellness-focused and recreational consumers. Its approach to targeting limited-license states helps the company reduce competition. Green Thumb’s combination of operational scale and retail experience gives it a strong advantage in the U.S. cannabis market. The company continues to expand cautiously, focusing on high-return markets and efficiency.

Financial Overview

Green Thumb posted solid financial results for the first quarter of 2025. Total revenue reached $310 million, a 10% gain from the previous year. The company’s gross margin came in at 58%, signaling good cost management. Adjusted EBITDA was $90 million, indicating consistent profitability and disciplined growth.

Green Thumb also reported having $180 million in cash and equivalents. This strong liquidity supports its expansion strategy and long-term investment goals. The company remains focused on margin improvement and scalable growth. With a steady financial base and disciplined execution, Green Thumb is a strong contender in the cannabis industry and one of the best stocks to watch this month.

Cannabis Stocks Poised for Growth

The U.S. cannabis industry is entering a new phase of maturity; moreover, strong growth projections lie ahead. Companies like Trulieve, Curaleaf, and Green Thumb have already built the scale and infrastructure to thrive in this environment. In addition, their consistent financial performance and expanding operations make them top stocks to monitor in May 2025. As a result, these companies are well-positioned for future gains. Furthermore, as legalization continues and demand rises, these companies could deliver long-term value for investors.

The post Marijuana Market Set to Surge by 2030—Here Are This Week’s Top U.S. Stock Picks appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Marijuana stock investors are working to stay poised during this ongoing volatile downtrend. Now even though the public sector is in a downtrend has not stopped industry progression as companies continue to generate large amounts of revenue. The cannabis industry has seen significant advancements in 2025. Much of which has been marked by increased and improved legalization. In addition to more companies working with technological innovations, and an expanding health and wellness market with cannabis as the focus.

More states and countries are recognizing the potential economic benefits of cannabis. With this, an increase in the growing number of regions have legalized both medicinal and recreational use. This expanded legal framework has attracted major investors which is why the frustrations are at an all-time high with the public sector. To enhance the trading performance of cannabis stocks, several scenarios could be beneficial. Firstly, greater transparency and standardization in product labeling can build consumer trust and confidence in cannabis products.

Additionally, enhancing regulatory clarity can attract institutional investors who have previously avoided the sector due to legal uncertainties. All of the above play a factor in trusting the market regardless of what is occurring. It is a classic risk vs reward with how things are in the sector. Nevertheless, there is still optimistic speculation for some shareholders and investors. Below are several marijuana stocks to watch and learn about over the Memorial Day break.

Marijuana Stocks To Know About In 2025

1. Leafly Holdings, Inc. (OTC:LFLY)
2. WM Technology, Inc. (NASDAQ:MAPS)
3. High Tide Inc. (NASDAQ:HITI)

Leafly Holdings, Inc.

Leafly Holdings, Inc. operates as an online cannabis discovery marketplace and resource in the United States and internationally. It has been a bit of time since the company has released any current updates.

However, on January 16th, the company held a receipt of notice of delisting from the Nasdaq and transition to OTC market.

WM Technology, Inc.

WM Technology, Inc., an online cannabis marketplace, provides ecommerce and compliance software solutions to retailers and brands in cannabis market in the United States and internationally. On May 8th the company reported its Q1 2025 results.

First Quarter 2025 Financial Highlights

• Revenues for the first quarter ended March 31, 2025 was $44.6 million as compared to $44.4 million in the prior year period.
• Average monthly paying clients(1) of 5,179 increased from 4,937 in the prior year period, largely due to new client acquisitions across certain markets.
• Net income increased to $2.5 million from $2.0 million in the prior year period.
• Adjusted EBITDA(3) increased to $10.1 million from $9.6 million in the prior year period.

[Read More] Top Marijuana Stocks In A Volatile Market

Words From The Company

“Our first quarter results reflect focused execution in what remains a challenging environment for the cannabis industry,” said Doug Francis, CEO of WM Technology. ”

[Read More] 2025’s Best Cannabis REITs for Building Wealth Over Time

High Tide Inc.

High Tide Inc. engages in the cannabis retail business in Canada, the United States, and internationally. It operates through Bricks and Mortar Operations; and E-commerce Operations segments.

In recent news the company announced the opening of new Canna Cabana store in Cornwall, Ontario. This opening brings High Tide’s total store count to 197 Canna Cabana branded locations across Canada, and 81 in the province of Ontario.

The post 3 Marijuana Stocks That Could Be The Long Term Money Maker appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Right now, cannabis companies are still reporting Q1 2025 earnings, and for most things, are looking good. It is undeniable how well the cannabis industry is doing, even as the road ahead is still a tough one. Profits are being made and growth is occurring throughout the sector.

But this has yet to help how marijuana stocks perform. There has been a volatile downturn for some time, and even with the progress of business pot stocks won’t move up. Now, with this success for legal operators around the globe, it gives hope for those who want to enter the sector. For instance, watching how an MSO powerhouse like Trulieve can make all this money but trade poorly. Yet even with the market down, the success outside of the public sector keeps positive speculation going. Many feel this is the time to find top marijuana stocks to buy.

People feel the future is where the gains will be made. A classic buy-and-hold long-term strategy is what many are feeling will be the better option. When federal reform matters are met, it has the potential to bring the trading up in a major way. Many are keeping watch for any volatile pops o trading to take profits until the big payday occurs. Below are several marijuana stocks to watch today.

Marijuana Stocks For Investors Who Like Legal Cannabis 2025

1. Tilray Brands, Inc. (NASDAQ:TLRY)
2. Canopy Growth Corporation (NASDAQ:CGC)
3. Cronos Group Inc.(NASDAQ:CRON)

Tilray Brands, Inc.

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. 

The company recently announced that its wholly-owned subsidiary, High Park Holdings Ltd., is launching XMG Atomic Sours. This product is a new line of cannabis beverages and gummies that redefine the sour experience.

Canopy Growth Corporation

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally.

Recently, the company announced it will release its Q1 2025 financial results on May 30th. Following the release of its fourth quarter and fiscal year 2025 financial results, Canopy Growth will host an audio webcast with Luc Mongeau, CEO, and Judy Hong, CFO.

[Read More] Marijuana Stocks To Buy Today And Trade Tomorrow?

Cronos Group Inc.

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. Back on May 8th, the company reported its Q1 2025 earnings.

[Read More] Top Performing U.S. Marijuana Stocks to Watch in 2025

2025 Highlights And Key Mentions

• Net revenue of $32.3 million in Q1 2025 increased by $7.0 million from Q1 2024.
• Gross profit of $13.7 million in Q1 2025 increased by $9.3 million from Q1 2024.
• Adjusted Gross Profit of $14.3 million in Q1 2025 increased by $9.8 million from Q1 2024.
• Net income of $7.7 million in Q1 2025 increased by $10.2 million from Q1 2024.

The post Top Marijuana Stocks In A Volatile Market appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry remains on a strong growth path, with projections estimating a $45 billion market in 2025. More than 20 states now allow adult recreational cannabis use, while others continue expanding medical programs. Recently, lawmakers have debated cannabis reform at the federal level, including rescheduling cannabis to a lower-risk drug classification. This shift could bring major tax relief and open new financial opportunities for cannabis companies. Despite challenges, these changes are fueling optimism across the sector. Penny stocks in this space offer low entry prices and potential for large percentage gains. As the market responds to legislative updates, investor attention has increased on smaller-cap cannabis plays with aggressive growth plans.

Although these stocks carry promise, they also come with significant risks. Many are highly volatile and trade with low daily volume. For this reason, using technical analysis is crucial when watching or trading marijuana penny stocks. Traders should examine key support and resistance levels. It is also smart to use volume indicators and trend confirmation tools. Setting stop-loss orders and managing position sizes can reduce exposure to large losses. Since these stocks can react sharply to news, disciplined entries and exits are essential. Investors must stay alert, follow news catalysts, and apply sound risk strategies. With the right tools and timing, opportunities in marijuana penny stocks can be substantial.

U.S. Cannabis Stocks to Add to Your Radar Now

As the U.S. cannabis industry continues expanding, investors are closely watching select leaders in the sector. In addition, more states are pushing for legalization, which adds to investor optimism. As a result, top-performing marijuana companies are gaining momentum in the market. This article focuses on three U.S. marijuana stocks worth watching in May 2025: Planet 13 Holdings (PLNH), Glass House Brands (GLASF), and Cresco Labs (CRLBF).

Each of these companies has a strong presence in key U.S. markets. They also continue to evolve operationally while navigating regulatory developments. Despite short-term volatility, these stocks have shown resilience and potential for long-term growth. Below is a closer look at each of these top cannabis players, their U.S. dispensary presence, and their latest financial performance.

[Read More] Marijuana Stocks To Buy Today And Trade Tomorrow?

Top U.S. Marijuana Stocks to Watch in May 2025

1. Planet 13 Holdings Inc. (OTC: PLNH)
2. Glass House Brands Inc. (OTC: GLASF)
3. Cresco Labs Inc. (OTC: CRLBF)

Planet 13 Holdings Inc. (PLNH)

Planet 13 Holdings is best known for operating the largest cannabis dispensary in the world. This flagship location is in Las Vegas, Nevada, and spans over 112,000 square feet. The store offers a unique retail experience that blends cannabis shopping with interactive entertainment. Tourists and locals alike visit the store daily, making it a high-traffic location.

The company has also expanded into Florida, which remains one of the fastest-growing medical cannabis markets. Currently, Planet 13 operates 30 dispensaries throughout Florida. It also has one location in Illinois, bringing its total count to 32 dispensaries. Its expansion strategy focuses on large-scale stores in high-demand regions. This allows the company to maintain brand recognition and customer loyalty.

With its growing footprint and strong consumer appeal, Planet 13 remains one of the most prominent names in the cannabis industry. Its multi-state operations continue to drive future growth opportunities.

Latest Financials

In its most recent quarterly report, Planet 13 posted revenue of $28 million. This marked a notable increase from the prior year’s results. The rise in revenue was largely driven by sales in Florida and continued strength in Las Vegas. Gross profits came in at $12 million, with a gross margin just above 42 percent.

Despite solid revenue growth, the company reported a net loss of $2 million. This was due to higher operating expenses tied to expansion efforts. Its adjusted EBITDA showed a loss of $2.5 million. However, management emphasized that short-term losses were strategic. The focus remains on building long-term value through market growth.

Planet 13 has sufficient liquidity to support future investments. Management is optimistic about Florida’s contribution to revenue in future quarters. Overall, the company is positioning itself for improved profitability as it scales.

[Read More] Cultivate Your Portfolio: U.S. Cannabis Stocks for May 2025

Glass House Brands Inc. (GLASF)

Glass House Brands is a vertically integrated cannabis company based in California. The company focuses exclusively on operations within the state. It operates greenhouse cultivation, manufacturing, distribution, and retail stores. This end-to-end control gives the company strong cost advantages.

The company has multiple dispensaries under its Farmacy brand. Most of these stores are located in high-traffic areas in Southern California. In total, Glass House operates eight dispensaries throughout the state. The company is known for its high-quality, sun-grown cannabis. Its cultivation facilities are among the largest in the country.

Glass House continues to expand its greenhouse capacity. This allows it to scale production without significantly increasing costs. The company’s strategy is rooted in operational efficiency and product consistency. As a result, it has become a leader in California’s highly competitive cannabis market. Its premium brand is well recognized by both medical and recreational consumers.

Latest Financials

In its latest earnings report, Glass House generated $44.8 million in revenue, a strong year-over-year increase driven by volume growth. Seasonal demand fluctuations and wholesale pricing pressures impacted the company’s performance, but it managed to maintain growth in core retail locations.

Gross margins remained relatively stable compared to the prior quarter. However, net losses were reported due to temporary increases in labor and facility costs. Management continues to emphasize its commitment to cost control. The company is also investing in automation to enhance productivity.

Cash reserves remain healthy and support ongoing expansion plans. While short-term headwinds persist in the California market, Glass House maintains its long-term bullish outlook. Its large cultivation assets provide a strong advantage. The company believes scale and quality will drive future margins. Therefore, investors continue to monitor Glass House as a top West Coast player.

[Read More]  These Cannabis Stocks Could Pay Off Big In The Future

Cresco Labs Inc. (CRLBF)

Cresco Labs is a multi-state cannabis operator based in Chicago, Illinois. The company is vertically integrated and offers products across nine key U.S. states. Its retail presence includes states like Florida, Illinois, Pennsylvania, and Massachusetts. Cresco Labs markets its dispensaries under the “Sunnyside” brand.

As of May 2025, Cresco operates 71 dispensaries across six states. Its stores are strategically located in both high-density urban centers and suburban areas. The company also owns several well-known consumer cannabis brands. These brands cater to a wide range of user preferences.

Cresco Labs has focused heavily on market depth rather than broad expansion. It prioritizes establishing strong brand loyalty in each region. This approach allows for efficient scaling and better customer service. The company’s mission is to normalize cannabis use through consistent and professional experiences. Cresco remains one of the largest cannabis companies by retail footprint in the U.S.

Latest Financials

Cresco Labs has delayed the release of its Q1 2025 earnings. However, previous performance trends provide some insight. In its last reported quarter, the company generated revenue of over $190 million, supported by strong retail performance in Florida and Illinois.

Gross profit margins hovered around 50 percent, consistent with prior quarters. The company previously reported a net loss, largely due to one-time restructuring costs. However, the adjusted EBITDA remained positive, showing that the business is generating operating cash flow.

Management has reaffirmed its commitment to reducing costs and improving margins. It is also working to optimize its supply chain. The delayed report is expected to include updates on the restructuring’s progress. Despite short-term challenges, Cresco remains financially stable. It continues to focus on market leadership in limited-license states.

U.S. Cannabis Stocks Catching Investor Attention This Week

In conclusion, the U.S. cannabis sector remains a dynamic and evolving space filled with both risk and opportunity. As legalization efforts continue across the country, investor interest in marijuana stocks is expected to grow. Companies like Planet 13, Glass House Brands, and Cresco Labs are positioning themselves for long-term success through strategic expansion and brand development. However, due to market volatility, it is essential to apply technical analysis and manage risk carefully.

Monitoring price action, volume, and key levels can help identify smarter entry points. Setting stop-losses and staying informed on regulatory changes will also support better decision-making. With proper research and a disciplined approach, investors can capitalize on momentum in this exciting sector. As always, focus on strong fundamentals, clear trends, and market-moving news to maximize cannabis-related opportunities. Now is the time to watch these top marijuana stocks as the U.S. industry moves toward broader acceptance.

The post Top Performing U.S. Marijuana Stocks to Watch in 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The cannabis industry is still showing signs of profitability, with companies reporting strong 2025 earnings. Much of the legal market, even with its uphill battle, is standing strong. This shows people that even though it is not federally legal, there is still an abundance of success at the state level. As well as other legal markets in various global regions, all of which play a big role as a whole for cannabis.

Yet much of this success has not exactly translated into better trading for public cannabis companies. The bulk of marijuana stocks are still facing a massive downtrend. However, there is hope for the future and daily bounces that many investors want to take gains as they come. Now, due to how unpredictable the sector can be, there is no way to know when a monumental bounce will happen.

So the idea is that as things progress for legal cannabis down the line, that will help fuel better trading for cannabis stocks. Many feel that once federal reform comes into play, it will ease volatile trading. Most shareholders do not feel safe to make trades or invest as they would with it in place. Cannabis should be seen as a legitimate industry like any other, especially with the large tax revenue legal states are making. Hopefully, this will soon carry over to the public sector to help some of these top marijuana stocks to watch today.

Marijuana Stocks For Long-Term Investing

1. Trulieve Cannabis Corp. (OTC:TCNNF)
2. GrowGeneration Corp. (NASDAQ:GRWG)
3. Curaleaf Holdings, Inc. (OTC:CURLF)

Trulieve Cannabis Corp.

Trulieve Cannabis Corp. operates as a cannabis retailer. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. 

In more recent news the company announced the opening of a new Trulieve-branded dispensary in Lorain, Ohio. Harvest Grows LLC will operate the dispensary under the Trulieve brand through a licensing agreement with the Company.

Words From The Company

“We are thrilled to open this new dispensary under our licensing agreement with Trulieve,” said Harvest’s Chief Executive Officer, Mark Eiland. “We are proud to be associated with the Trulieve brand and look forward to serving customers at this new location.”

[Read More] These 2 Marijuana Stocks Are Making Money Outside Of The Stock Market

GrowGeneration Corp.

GrowGeneration Corp., through its subsidiaries, owns and operates retail hydroponic and organic gardening stores in the United States. It operates through two segments, Cultivation and Gardening, and Storage Solutions. Recently, the company announced the launch of MMI Storage Solutions’ new mobile package and luggage solution.

It was designed exclusively for the Waldorf Astoria, one of the world’s most iconic luxury hotel brands. This custom-engineered system will elevate the Waldorf guest experience. The new setup will be done by providing hotel staff with an elegant, efficient, and secure way to handle guest luggage.

[Read More] 3 Marijuana Stocks For Cannabis Real Estate Investors

Curaleaf Holdings, Inc.

Curaleaf Holdings, Inc. produces and distributes cannabis products in the United States and internationally. On May 16th the company released news regarding the opening of a new dispensary in Lima Ohio.

The store expands Curaleaf’s footprint in the Buckeye State to three stores, bringing the Company’s nationwide retail footprint to 152 locations. Curaleaf Lima will increase convenient access to high-quality cannabis for both medical patients and adult-use customers across northwest Ohio.

The post Marijuana Stocks To Buy Today And Trade Tomorrow? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

In recent weeks, cannabis penny stocks have attracted cautious investor interest. First, the U.S. legal cannabis market reached $33.6 billion in 2023. Moreover, it is projected to grow at a 12.1 percent CAGR through 2030. Meanwhile, employment in the sector surpassed 440,000 full‑time jobs nationwide. At the same time, federal reform remains stalled despite rescheduling momentum. For instance, the DEA’s proposed move to Schedule III could reshape banking access. In addition, states push new bills. Notably, Pennsylvania lawmakers debate privatized dispensaries to unlock $250 million in annual tax revenue. Likewise, the Supreme Court’s recent RICO decision heightens compliance risks across the industry. Therefore, cannabis penny stocks offer both opportunity and volatility this week. Consequently, traders should combine fundamental awareness with market context before entry.

Furthermore, technical analysis can guide precise entry and exit points. For example, watch for clear breakouts above key moving averages. Likewise, identify volume spikes on relative strength index (RSI) signals near oversold levels. At the same time, set stop-loss orders below recent swing lows to limit downside. Moreover, position sizing based on a fixed percentage of portfolio capital prevents outsized losses. In addition, traders should monitor broader market correlations to cannabis ETFs and equities.

Meanwhile, avoid headline risks, such as state-level vetoes or federal delays. Finally, combine chart patterns—like double bottoms or bullish engulfing candles—with strict risk rules. By doing so, investors can pursue gains in penny stocks while containing exposure in this still-evolving industry.

[Read More] These Cannabis Stocks Could Pay Off Big In The Future

Top U.S. Marijuana Stocks to Watch in May 2025

The Cannabist Company Holdings Inc. (OTC: CBSTF)

Cansortium Inc. (OTC: CNTMF) – Doing Business as Fluent

Verano Holdings Corp. (OTC: VRNOF)

The Cannabist Company Holdings Inc. (OTC: CBSTF)

The Cannabist Company, previously known as Columbia Care, is one of the largest vertically integrated cannabis firms in the U.S. Its largest presence is in Florida, New York, and Virginia. As of May 2025, it operates 67 dispensaries across 14 U.S. states. In addition, the company runs 17 cultivation and processing facilities. It offers branded products through in-house lines like Triple Seven and Seed & Strain. Its retail stores are focused on a consistent customer experience. Furthermore, the company has embraced digital marketing and loyalty programs. This helps build stronger customer retention. Recently, it has closed underperforming locations in saturated markets. At the same time, it is focusing on growing markets with long-term upside. These strategic shifts aim to boost margins and reduce overhead. The company focuses on improving operations, scaling sustainably, and navigating changing regulations.

In Q1 2025, the Cannabist Company reported $87 million in revenue. This was slightly lower than the same quarter last year. However, the company improved gross margins by reducing operational costs and optimizing cultivation. Management also reduced SG&A expenses. This improved operational efficiency across its footprint. The net loss narrowed meaningfully compared to the prior year. Additionally, the company successfully restructured a portion of its debt. Lower interest costs are expected in future quarters. Adjusted EBITDA showed improvement, even with modest revenue softness. Cash from operations turned positive for the first time in several quarters. This is a key sign of improving financial health. Liquidity also improved due to better inventory management. Looking forward, management expects stabilization through the second half of 2025. As a result, the company is well-positioned to benefit from future industry growth.

[Read More] Best Canadian Marijuana Stocks for U.S. Market Exposure

 Cansortium Inc. (OTC: CNTMF) – Doing Business as Fluent

Cansortium Inc., now operating as Fluent, is a medical marijuana operator with a strong Florida focus. The company currently operates over 30 dispensaries in Florida alone. Outside Florida, it operates in Texas, Pennsylvania, and New York. Fluent also recently expanded into Ohio, adding several co-located dispensaries. Its brand is built on wellness and customer education. Many locations offer pharmacist-led consultations. This builds trust and improves patient experience. Fluent offers a wide range of products. These include flower, concentrates, tinctures, and pre-rolls. The company continues to grow by adding high-performing retail sites in emerging markets. It also seeks joint ventures and local partnerships to reduce entry barriers. With a vertically integrated model, it controls the supply chain from seed to sale. This gives it pricing flexibility and operational consistency. Fluent remains committed to steady, profitable growth in medically focused markets.

Fluent posted $63.8 million in revenue for Q1 2025. This marked a slight decline year-over-year. Retail sales fell slightly due to price compression, though overall unit volume increased. Wholesale sales declined as bulk deals slowed in some markets. However, states like Virginia and Ohio posted strong retail gains. Gross profit came in at $25.8 million, with margins compressed slightly from prior quarters. Operating expenses totaled $27.6 million, which was a modest improvement. Fluent reported a net loss of $17 million in Q1. Interest expenses and depreciation continued to weigh on results. However, adjusted EBITDA was $9.8 million, down from $13.3 million in the previous year. Despite short-term softness, the company’s financials are stabilizing. Investments in Ohio and Virginia are expected to deliver growth in future quarters. Fluent is also improving cash flow and reducing non-essential costs. These steps should help strengthen its financial foundation.

[Read More] 3 Marijuana Stocks For Long-Term Investing 2025

Verano Holdings Corp. (OTC: VRNOF)

Verano Holdings is a major multi-state cannabis operator based in Chicago. It operates in 16 U.S. states and serves both medical and adult-use markets. As of May 2025, Verano runs more than 100 dispensaries. Its largest retail presence is in Florida, Illinois, and Nevada. Verano is known for its premium retail brands like Verano and MÜV. These stores are highly curated and focus on customer experience. The company also owns cultivation and processing facilities in key states. It uses vertical integration to manage costs and ensure consistent product quality. Verano expands through both organic growth and acquisitions. Recent moves have focused on acquiring licenses in underserved regions. It also partners with local operators to reduce risk. Leadership has emphasized careful scaling and integration. As a result, the brand reputation remains strong across regions. The company’s structure supports long-term scalability and margin growth.

In Q1 2025, Verano reported $210 million in revenue. This marked a strong increase compared to the prior year. The company recorded a net loss of $12 million for the quarter. However, adjusted EBITDA improved as gross margins expanded. Verano also generated $2 million in operating cash flow. Although capital expenditures remained high, the company managed costs effectively. Its balance sheet remains healthy, with reasonable levels of debt and cash on hand. Management continues to reinvest in new store openings and cultivation upgrades. These investments are expected to fuel future revenue growth. The company aims to reach profitability by late 2026. Analysts have highlighted Verano’s disciplined approach as a key advantage. By focusing on core markets and sustainable operations, it has built a resilient business model. Financial performance is expected to improve further as markets mature and efficiencies scale.

Leading U.S. Marijuana Stocks for May 2025

May 2025 presents a unique moment for cannabis investors. The U.S. industry is expanding amid evolving legalization trends. Companies like The Cannabist Company, Fluent, and Verano offer diverse exposure. Each firm operates in multiple states and controls a significant market share. Despite recent margin pressures, they are improving operational efficiency and cash flow. These names are well-positioned for long-term success in the cannabis sector. For investors, they represent top U.S. marijuana stocks to watch in 2025.

The post Cultivate Your Portfolio: U.S. Cannabis Stocks for May 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Charlotte’s Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF),  (“Charlotte’s Web” or the “Company”), a botanical wellness innovation company, today announced results for the quarter ended March 31, 2025, reporting its first year-over-year revenue increase in more than three years, building on the sequential quarterly growth trend achieved in 2024.

“Following three sequential quarters of improvement in 2024, Q1 delivered our first year-over-year revenue growth since 2021 – validating the transformation we initiated 18 months ago,” said Bill Morachnick, Chief Executive Officer. “Our upgraded e-commerce platform is converting more visitors, and new digital storefronts on Amazon, TikTok Shop, and Faire are widening our reach. An upcoming nationwide rollout with Whole Foods Market will strengthen our retail footprint. Operationally, we commenced initial in–house gummy production and, as part of our disciplined cost agenda, we mutually concluded our promotional rights agreement with MLB and associated costs. Coupled with robust innovation – including cannabinoid isolates and our new functional mushroom gummy line – we believe these initiatives position the Company to deliver top and bottom-line growth for 2025 and beyond.”

Erika Lind, Chief Financial Officer, added, “Our reengineered cost structure is now flowing through the P&L. Building on the positive traction from the prior quarters, we are structuring for further improvements in cost efficiency and cash flow. As a part of this effort, we have concluded some high-cost promotional sports agreements, thereby eliminating sizeable future cash outlays of more than $18 million over the next three years. This supports near-term cash flow and preserves long-term cash for further investment in innovation. Combined with our transitioning to in-house manufacturing and disciplined SG&A control, we anticipate further improvements to cash flow in 2025.”

First Quarter Business Review

Expansion of Mushroom Wellness Gummy Innovations
Following the successful Q4 2024 launch of its functional mushroom gummies targeting focus, stress, and energy, Charlotte’s Web will continue expanding its botanical wellness portfolio in 2025. The Company’s strategic diversification beyond CBD is gaining market traction with mushroom wellness products now available through multiple distribution channels, including Walmart.com, Amazon.com, and the Company’s direct-to-consumer platform.

E-Commerce Growth and Omnichannel Expansion
Building on the sequential gains recorded in 2024, Charlotte’s Web’s digital channels delivered year-over-year growth in Q1 2025. Order volume growth, stabilized average order values, new subscriber increases, and lower churn rates drove meaningful digital revenue growth and underscored brand loyalty. This performance reflects the past year’s technology and go-to-market enhancements: a unified brand architecture, an expanded product portfolio, data-driven segmentation, an upgraded e-commerce stack, and improved engagement tools such as SMS outreach and an influencer network that now reaches more than one million consumers.

The Company has widened its omnichannel footprint. Walmart.com added Charlotte’s Web’s new mushroom wellness gummies during the quarter, while strategic launches on Amazon, TikTok Shop, and Faire have dramatically broadened online reach. With additional categories and channels slated for launch in the coming quarters, the Company is well-positioned to meet consumers wherever they shop, diversifying revenue streams, and capturing incremental market share through improved digital discoverability.

Whole Foods Market Retail Distribution Launch
In a significant advancement of its retail expansion, the Company achieved a major milestone finalizing an agreement with Whole Foods Market to roll out products to more than 400 store locations nationwide. As part of this partnership, three isolate topical products will be available on shelves starting June 2025. This launch marks a significant step forward in making botanical wellness solutions more accessible to health-conscious consumers seeking trusted, plant-based alternatives.

Operational Efficiencies and Cost Management
Expense reductions initiated in 2024 continued to benefit operating performance, with year-over-year operating costs down 24.2%. Strengthening operations, Charlotte’s Web began preliminary in-house commercial production of gummies in Q2 2025, supporting gross margins and speed-to-market for new products. This production shift will enable the rapid development of new gummy blends.

“With successful expansion into new product categories, improving cash flow metrics, and enhanced operational efficiencies, Charlotte’s Web has a good start to 2025,” added Mr. Morachnick. “Our disciplined execution of strategic initiatives – from platform expansion to manufacturing optimization – positions us to build on this throughout 2025 and beyond, delivering value for shareholders and continued innovation for consumers.”

DeFloria Milestone
In the first quarter, DeFloria, Inc. – a joint entity established between Charlotte’s Web and Ajna BioSciences, with British American Tobacco as lead investor – received U.S. Food and Drug Administration (FDA) clearance to initiate Phase 2 clinical trials for its botanical pharmaceutical candidate, AJA001 Oral Solution, intended to treat irritability associated with autism spectrum disorder (“ASD”). AJA001 is formulated using Charlotte’s Web proprietary full-spectrum CBD extract derived from its patented cultivars. The FDA’s acceptance of DeFloria’s IND for AJA001 marks a significant milestone. In addition, Charlotte’s Web holds manufacturing rights for commercial supply when the drug is ultimately approved by the FDA, representing a potential opportunity that could be transformative for Charlotte’s Web over time.

On June 9, 2025, Charlotte’s Web and Ajna BioSciences will host an executive panel session at the Benzinga Cannabis Capital Conference in Chicago. As part of the panel discussion, Charlotte’s Web will showcase its partnership with DeFloria and AJA001’s clinical progress and therapeutic potential. For attendance information, contact IR@defloira.bio.

First Quarter 2025 Financial Review
The following table sets forth selected financial information for the periods indicated:

Three months ended

March 31,

U.S. $ millions, except per share data

2025

2024

Revenue

$

12.3

$

12.1

Cost of goods sold

$

6.1

$

5.2

Gross profit

6.2

6.9

Selling, general and administrative expenses

11.6

15.3

Operating loss

(5.4)

(8.4)

Change in fair value of financial instruments and other

(0.1)

(1.9)

Other income (expense) , net

(0.7)

0.6

Net loss

$

(6.2)

$

(9.7)

EPS basic and diluted

$

(0.04)

$

(0.06)

Adjusted EBITDA(1)

$

(2.8)

$

(3.9)

Assets:

Cash and cash equivalents

$

19.4

Total assets

$

108.0

Liabilities:

Long-term liabilities

$

68.5

Total liabilities

$

87.0

Quarterly revenue trend:

Q1

Q2

Q3

Q4

Q1

U.S. $ millions

2024

2024

2024

2024

2025

Total revenue

$ 12.1

$ 12.3

$ 12.6

$ 12.7

$ 12.3

Consolidated net revenue for the first quarter ended March 31, 2025, was $12.3 million, a year-over-year increase of 1.1% compared to $12.1 million in the first quarter of 2024. Propelled by the continued performance of the Company’s upgraded e-commerce platform, this represents the first period of year-over-year growth reported since Q2 2021 and builds upon a consecutive quarterly growth trend established in 2024. Introduced in mid-2024, the new platform has delivered measurable improvements in marketing effectiveness, customer engagement, and sales volumes. The Company also continues to generally outperform its peers in retail category benchmarks, reflecting the strength of its recent product innovations and the effectiveness of its strategic retail partnerships.

Gross profit in Q1 2025 was $6.2 million, or 50.8% of revenue, compared to gross profit of $6.9 million, or 57.0% of revenue, in Q1 2024. The prior year included temporary items favorable to gross margin. The Company models forward gross margin percentages to continue in the low 50s, supported partly by the transition to in-house production of gummies, followed by topical products over time.

Total selling, general, and administrative (“SG&A”) expenses in the quarter were $11.6 million, a 24.2% improvement from $15.3 million in Q1 2024. Stringent expense controls were implemented over the past year and remain a central focus in 2025.

Net loss for the first quarter of 2025 was $6.2 million, or ($0.04) per share basic and diluted, compared to a net loss of $9.7 million, or ($0.06) per share basic and diluted, for the first quarter of 2024.

Excluding depreciation, amortization and other non-cash items, Charlotte’s Web reported negative Adjusted EBITDA1 for the first quarter of 2025 of $2.8 million, a $1.1 million improvement compared to negative Adjusted EBITDA of $3.9 million in the first quarter of 2024.

Balance Sheet and Cash Flow
Net cash used for operations in the first quarter of 2025 was $2.8 million. The Company’s cash and working capital as of March 31, 2025, were $19.4 million and $25.5 million, respectively, compared to $22.6 million and $31.1 million as of December 31, 2024, respectively.

“With cash reserves exceeding $19 million and our anticipated cash flow improvements for this year, we are confident our balance sheet is sufficient to support growth for 2025 and beyond,” said Mrs. Lind.

Consolidated Financial Statements and Management’s Discussion and Analysis
The Company’s consolidated financial statements and accompanying notes for the three month periods ended March 31, 2025, and 2024, and related management’s discussion and analysis of financial condition and results of operations (“MD&A”), are reported in the Company’s 10-Q filing on the Securities and Exchange Commission website at www.sec.gov and on SEDAR+ at www.sedarplus.ca and will be available on the Investor Relations section of the Company’s website at https://investors.charlottesweb.com.

About Charlotte’s Web Holdings, Inc.
Charlotte’s Web Holdings, Inc., a Certified B Corporation headquartered in Louisville, Colorado, is a botanical wellness innovation company and market leader in hemp extract wellness that includes Charlotte’s Web whole-plant full-spectrum CBD extracts as well as broad-spectrum CBD. Charlotte’s Web branded premium quality full-spectrum CBD extract products start with proprietary hemp genetics that are North American farm-grown using organic and regenerative cultivation practices. The Company’s hemp extracts have naturally occurring botanical compounds including cannabidiol (“CBD”), CBN, CBC, CBG, terpenes, flavonoids, and other beneficial compounds. Charlotte’s Web product categories include CBD oil tinctures (liquid products), CBD gummies (sleep, calming, exercise recovery, immunity), CBN gummies, functional mushroom gummies, CBD capsules, CBD topical creams, and lotions, as well as CBD pet products for dogs. Through its substantially vertically integrated business model, Charlotte’s Web maintains stringent control over product quality and consistency with analytic testing from soil to shelf for quality assurance. Charlotte’s Web products are distributed to retailers and healthcare practitioners throughout the U.S.A. and are available online through the Company’s website at www.charlottesweb.com.

Shares of Charlotte’s Web trade on the Toronto Stock Exchange (TSX) under the symbol “CWEB” and are quoted in U.S. Dollars in the United States on the OTCQX under the symbol “CWBHF”.

(1)

Non-GAAP Measures: The press release contains non-GAAP measures, including EBITDA and Adjusted EBITDA. Please refer to the section in the tables captioned “Non-GAAP Measures” below for additional information and a reconciliation to GAAP for all Non-GAAP metrics.

Forward-Looking Information

Certain information provided herein constitutes forward-looking statements or information (collectively, “forward-looking statements”) within the meaning of applicable securities laws. Forward-looking statements are typically identified by words such as “may”, “will”, “should”, “could”, “anticipate”, “expect”, “project”, “estimate”, “forecast”, “plan”, “intend”, “target”, “believe” and similar words suggesting future outcomes or statements regarding an outlook. Forward-looking statements are not guarantees of future performance, and readers are cautioned against placing undue reliance on forward-looking statements. By their nature, these statements involve a variety of assumptions, known and unknown risks and uncertainties, and other factors which may cause actual results, levels of activity, and achievements to differ materially from those expressed or implied by such statements. The forward-looking statements contained in this press release are based on certain assumptions and analysis by management of the Company in light of its experience and perception of historical trends, current conditions, expected future development, and other factors that it believes are appropriate and reasonable.

Specifically, this press release contains forward-looking statements relating to, but not limited to: organizational changes, marketing plans and operational platform upgrades, and the impact of these initiatives on retail expansion, operational efficiencies, cash flow,‎ revenue and e-commerce monetization; expectations relating to IT upgrades, marketing optimization and operational integrations; product expansion activities and the corresponding ‎results thereof; sales volume and gross margin expectations; anticipated timing for, and business impact of, in-house manufacturing of topical ‎and gummy products; ‎the impact of the Company’s product innovations on product development; regulatory developments and the impact of developments on both consumer action and the Company’s opportunities and operations; activities relating to, and sponsorship of, legislation to advance regulatory framework; the impact of insourcing on operating margins, capital expenditures and R&D; anticipated consumer trends and corresponding product innovation; anticipated future financial results; the Company’s ability to increase online traffic and demographic exposure through new products and marketing and omni-channel expansion; and the impact of certain activities on the Company’s business and financial condition and anticipated trajectory; launch of products in Whole Foods; continued product placement on various product channels; anticipated development of new products; the outcomes from DeFloria’s clinical trials, including commercial opportunities for Charlotte’s Web.

The material factors and assumptions used to develop the forward-looking statements herein include, but are not limited to: regulatory regime changes; anticipated product development and sales; the success of sales and marketing activities; product development and production expectations; outcomes from R&D activities; the Company’s ability to deal with adverse growing conditions in a timely and cost-effective manner; the availability of qualified and cost-effective human resources; compliance with contractual and regulatory obligations and requirements; availability of adequate liquidity and capital to support operations and business plans; and expectations around consumer product demand. In addition, the forward-looking statements are subject to risks and uncertainties pertaining to, among other things: supply and distribution chains; the market for the Company’s products; revenue fluctuations; regulatory changes; loss of customers and retail partners; retention and availability of talent; competing products; share price volatility; loss of proprietary information; product acceptance; internet and system infrastructure functionality; information technology security; available capital to fund operations and business plans; crop risk; economic and political considerations; and including but not limited to those risks and uncertainties discussed under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ending December 31, 2024, and other risk factors contained in other filings with the Securities and Exchange Commission available on www.sec.gov and filings with Canadian securities regulatory authorities available www.sedarplus.ca. The impact of any one risk, uncertainty, or factor on a particular forward-looking statement is not determinable with certainty, as these are interdependent, and the Company’s future course of action depends on management’s assessment of all information available at the relevant time.

Any forward-looking statement in this press release is based only on information currently available to the Company and speaks only as of the date on which it is made. Except as required by applicable law, the Company assumes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. All forward-looking statements, whether written or oral, attributable to the Company or persons acting on the Company’s behalf, are expressly qualified in their entirety by these cautionary statements.

CHARLOTTE’S WEB HOLDINGS, INC.CONSOLIDATED BALANCE SHEETS
(in thousands of U.S. dollars, except share and per share amounts)

March 31,

December 31,

2025 (unaudited)

2024

ASSETS

Current assets:

Cash and cash equivalents

$ 19,357

$ 22,618

Accounts receivable, net

1,531

1,263

Inventories, net

18,916

18,907

Prepaid expenses and other current assets

4,201

4,194

Total current assets

44,005

46,982

Property and equipment, net

25,758

26,337

License and media rights

12,717

13,691

Operating lease right-of-use assets, net

12,404

12,876

Investment in unconsolidated entity

10,700

10,800

SBH purchase option and other derivative assets

970

1,075

Intangible assets, net

1,003

1,049

Other long-term assets

466

632

Total assets

$ 108,023

$ 113,442

LIABILITIES AND SHAREHOLDERS’ EQUITY

Current liabilities:

Accounts payable

$ 3,943

$ 3,426

Accrued and other current liabilities

4,764

5,246

Lease obligations – current

1,844

2,055

License and media rights payable – current

7,937

5,209

Total current liabilities

18,488

15,936

Convertible debenture

44,753

43,631

Lease obligations

13,257

13,652

License and media rights payable

9,227

11,809

Derivative and other long-term liabilities

1,236

1,327

Total liabilities

86,961

86,355

Commitments and contingencies

Shareholders’ equity:

Common shares, nil par value; unlimited shares authorized; 158,009,541 and
158,009,541 shares issued and outstanding as of March 31, 2025 and December
31, 2024

1

1

Additional paid-in capital

328,842

328,655

Accumulated deficit

(307,781)

(301,569)

Total shareholders’ equity

21,062

27,087

Total liabilities and shareholders’ equity

$ 108,023

$ 113,442

CHARLOTTE’S WEB HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands of U.S. dollars, except share and per share amounts)

Three Months Ended March 31,
(unaudited)

2025

2024

Revenue

$ 12,262

$ 12,124

Cost of goods sold

6,032

5,213

Gross profit

6,230

6,911

Selling, general, and administrative expenses

11,578

15,280

Operating loss

(5,348)

(8,369)

Change in fair value of financial instruments

(126)

(1,860)

Other income (expense), net

(738)

611

Loss before provision for income taxes

$ (6,212)

$ (9,618)

Income tax expense

—

(16)

Net loss

$ (6,212)

$ (9,634)

Per common share amounts

Net loss per common share, basic and diluted

$ (0.04)

$ (0.06)

CHARLOTTE’S WEB HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(in thousands of U.S. dollars, except share amounts)

Common Shares

Additional
Paid-in
Capital

Accumulated
Deficit

Total
Shareholders’
Equity

Shares

Amount

Balance—December 31, 2024

158,009,541

$ 1

$ 328,655

$ (301,569)

$ 27,087

Common shares issued upon vesting of restricted share units,
net of withholding

—

—

—

—

—

Share-based compensation

—

—

187

—

187

Net loss

—

(6,212)

(6,212)

Balance—March 31, 2025

158,009,541

$ 1

$ 328,842

$ (307,781)

$ 21,062

Balance—December 31, 2023

154,332,366

$ 1

$ 327,280

$ (271,723)

$ 55,558

Common shares issued upon vesting of restricted share units,
net of withholding

2,895,489

—

(98)

—

(98)

Share-based compensation

—

842

—

842

Net loss

—

(9,634)

(9,634)

Balance—March 31, 2024

157,227,855

$ 1

$ 328,024

$ (281,357)

$ 46,668

CHARLOTTE’S WEB HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands of U.S. dollars)

Three Months Ended March 31,
(unaudited)

2025

2024

Cash flows from operating activities:

Net loss

$ (6,212)

$ (9,634)

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation and amortization

2,449

2,493

Change in fair value of financial instruments

126

1,860

Convertible debenture and other accrued interest

868

1,015

Changes in right-of-use assets

473

443

Share-based compensation

187

842

Other

126

(956)

Changes in operating assets and liabilities:

Accounts receivable, net

(394)

98

Inventories, net

19

(1,026)

Prepaid expenses and other current assets

28

150

License and media rights

—

(2,500)

Operating lease obligations

(605)

(551)

Accounts payable, accrued and other liabilities

71

663

Other operating assets and liabilities, net

96

(76)

Net cash used in operating activities

(2,768)

(7,179)

Cash flows from investing activities:

Purchases of property and equipment and intangible assets

(521)

(2,060)

Proceeds from sale of assets

28

27

Net cash used in investing activities

(493)

(2,033)

Cash flows from financing activities:

Other financing activities

—

(98)

Net cash used in financing activities

—

(98)

Net decrease in cash and cash equivalents

(3,261)

(9,310)

Cash and cash equivalents —beginning of period

22,618

47,820

Cash and cash equivalents —end of period

$ 19,357

$ 38,510

Non-cash activities:

Non-cash purchase of property and equipment and intangible assets

$ (83)

$ (374)

(1) Non-GAAP Measures – EBITDA and Adjusted EBITDA
Earnings before interest, taxes, depreciation, and amortization (“EBITDA”) is not a recognized performance measure under U.S. GAAP. The term EBITDA consists of net loss and excludes interest, taxes, depreciation, and amortization. Adjusted EBITDA also excludes other non-cash items such as changes in fair value of financial instruments (Mark-to-Market), Share-based compensation, and impairment of assets. These non-GAAP financial measures should be considered supplemental to, and not a substitute for, our reported financial results prepared in accordance with GAAP. The non-GAAP financial measures do not have a standardized meaning prescribed under U.S. GAAP and, therefore, may not be comparable to similar measures presented by other issuers. The primary purpose of using non-GAAP financial measures is to provide supplemental information that we believe may be useful to investors and to enable investors to evaluate our results in the same way we do. We also present the non-GAAP financial measures because we believe they assist investors in comparing our performance across reporting periods on a consistent basis, as well as comparing our results against the results of other companies, by excluding items that we do not believe are indicative of our core operating performance. Specifically, we use these non-GAAP measures as measures of operating performance; to prepare our annual operating budget; to allocate resources to enhance the financial performance of our business; to evaluate the effectiveness of our business strategies; to provide consistency and comparability with past financial performance; to facilitate a comparison of our results with those of other companies, many of which use similar non-GAAP financial measures to supplement their GAAP results; and in communications with our board of directors concerning our financial performance. Investors should be aware, however, that not all companies define these non-GAAP measures consistently.

Adjusted EBITDA for the three months ended March 31, 2025, and 2024 is as follows:

Charlotte’s Web Holdings, Inc.

Statement of Adjusted EBITDA

(In Thousands)

Three Months Ended
March 31,
(unaudited)

U.S. $ Thousands

2025

2024

Net loss

$

(6,212)

$

(9,618)

Depreciation of property and equipment and amortization of intangibles

2,449

2,493

Interest expense

685

487

Income tax expense

16

EBITDA

(3,078)

(6,622)

Share-based compensation

187

842

Mark-to-market financial instruments

126

1,860

Adjusted EBITDA

$

(2,765)

$

(3,920)

SOURCE Charlotte’s Web Holdings, Inc.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2025/14/c3289.html

The post Charlotte’s Web Holdings, Inc. (CWBHF) Reports Year-Over-Year Growth For Q1 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The cannabis industry has faced significant challenges in recent years, leading to a downturn in marijuana stock prices. Despite the current market conditions, there may be a strategic opportunity for investors. With how low the sector has fallen, this risk vs reward opportunity could be profitable. The cannabis sector needs a big momentum change and an impactful catalyst to do so.

This is where many feel the passing of federal reform will be the dominant shift for most marijuana stocks. Market corrections are often where real value is found. Cannabis stocks are currently trading at historically low price-to-sales and price-to-book ratios. What this means is investors can find top marijuana stocks to buy at steal valuations. Now, most of the time it is a waiting game as to when a volatile pop will occur, so long-term planning is what’s occurring.

In short, while the cannabis sector has faced headwinds, current lows may not reflect the long-term potential of the industry. For investors willing to be patient, the current downtrend could be a rare chance to buy low before the next wave of growth begins. Just make sure you do your research and develop a trading strategy that works for you. Below are several marijuana stocks to watch today.

Marijuana Stocks For Your 2025 Portfolio

1. FLUENT Corp. (OTC:CNTMF)
2. Glass House Brands Inc.(OTC:GLASF)
3. Ascend Wellness Holdings, Inc. (OTC:AAWH)

FLUENT Corp.

FLUENT Corp., through its subsidiaries, cultivates, manufactures processes, distributes, and sells medical cannabis products for medical and adult-use markets in Florida, New York, Pennsylvania, and Texas.

In recent news, the company released New York Minute, a bold new addition to its MOODS vaporizer portfolio. The new offering will be available in two convenient All-in-One device formats: a 1g Mini and a 0.5g Dash, catering to consumers who seek portability, performance,e and taste.

Words From The CEO

“New York sets the tone for culture, innovation, and lifestyle—and we wanted to create a vape product that connects with that essence,” said Robert Beasley, CEO of FLUENT.”

Glass House Brands Inc.

Glass House Brands Inc. operates as an integrated cannabis company in the United States. The company operates in three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packaged Goods.

The company has recently announced in partnership with LEEF Brands Inc. This Management Services Agreement Glass House will manage operations of LEEF’s Palm Desert, California, dispensary, “The Leaf El Paseo,” on behalf of LEEF. Glass House will assume daily management responsibilities of The Leaf El Paseo.

[Read More] 3 Marijuana Stocks For Long-Term Investing 2025

Ascend Wellness Holdings, Inc.

Ascend Wellness Holdings, Inc. engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States.

In recent updates, the company has reported its Q1 2025 earnings.

[Read More] Best Canadian Marijuana Stocks for U.S. Market Exposure

Financial Highlights
Revenue:

• Total net revenue declined 5.9% quarter-over-quarter to $128.0 million.
• Retail revenue decreased 6.6% quarter-over-quarter to $84.4 million.
• Wholesale revenue decreased 4.4% quarter-over-quarter to $43.6 million.
  Net Loss:
• Net loss of $19.3 million in Q1 2025 compared to net loss of $16.8 million in Q4 2024.

The post These Cannabis Stocks Could Pay Off Big In The Future appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues to surge, reaching an estimated $45 billion in 2025. Analysts expect it to grow to over $75 billion by 2030. With federal reform discussions advancing and legalization expanding, Canadian cannabis companies are positioning for growth. Many are making strategic moves to increase their U.S. exposure through acquisitions and partnerships.

This momentum has sparked investor interest in Canadian companies with operational ties to the U.S. These firms aim to capture future demand while waiting for federal legalization. This week, three stocks stand out: Tilray Brands Inc., Canopy Growth Corporation, and Village Farms International Inc. Each has taken bold steps to improve financial health and boost cross-border expansion. Let’s explore how these companies are performing and why they’re worth watching now.

[Read More] 3 Marijuana Stocks For Long-Term Investing 2025

Top Canadian Cannabis Stocks to Watch in May 2025

1. Tilray Brands Inc. (NASDAQ: TLRY)
2. Canopy Growth Corporation (NASDAQ: CGC)
3. Village Farms International Inc. (NASDAQ: VFF)

Tilray Brands Inc. (TLRY)

Tilray Brands Inc. is a diversified cannabis company with exposure to both wellness and beverage sectors. The company operates in Canada, Europe, and across the U.S. through THC-infused beverages and hemp-based products. In the U.S., Tilray distributes its THC drinks in over 10 states via various retail partnerships. Although it doesn’t own dispensaries, its beverages are stocked in liquor stores and convenience chains nationwide.

Tilray is also active in global markets. It has operations in Germany, Portugal, and Australia. These regions support both medical and recreational growth. Within North America, Tilray’s strategy focuses on consumer-packaged goods and market penetration through scalable partnerships. The company’s U.S. exposure continues to grow despite regulatory barriers.

In April 2025, Tilray reported its Q3 fiscal 2025 earnings. The company posted revenue of $185.8 million, slightly lower than last year. Gross profit rose 5% to $52 million. Gross margin improved to 28%, driven by cost controls and high-margin products.

Tilray’s cannabis segment delivered its strongest margin in two years. This result indicates progress in operational efficiency. However, the company posted a net loss of $793.5 million. This was mostly due to non-cash impairment charges that impacted reported earnings. Tilray also reduced its overall debt by $76 million. This move shows a commitment to long-term financial sustainability. Investors continue to monitor Tilray’s beverage expansion and cost-reduction initiatives for future performance.

[Read More] Top 3 Marijuana Stocks For Better Investing 2025

Canopy Growth Corporation (CGC)

Canopy Growth Corporation is one of the best-known cannabis producers in Canada. The company has multiple brands, including Tweed, Tokyo Smoke, and Martha Stewart CBD. Canopy has shifted its U.S. strategy through Canopy USA. This structure gives it exposure to American operators while complying with federal law.

Canopy USA controls stakes in several U.S. companies, including Wana, Jetty, and Acreage. These firms give Canopy access to edibles, vapes, and flower products. While Canopy cannot yet directly operate dispensaries in the U.S., this setup keeps it prepared for future legalization. The company’s brand portfolio remains one of its strongest assets.

In February 2025, Canopy reported its Q3 fiscal 2025 results. The company generated $74.8 million in revenue, a 5% drop from the prior year. However, revenue increased by 8% when excluding divested businesses. The company also reported a $24 million operating loss, but this marked a 61% improvement year-over-year.

Canopy’s medical cannabis business in Canada showed continued strength. International markets also contributed to stable revenue, especially in Europe. To improve its balance sheet, Canopy prepaid a $100 million loan. This will reduce interest costs and improve cash flow. Management continues to focus on operational efficiency and margin recovery. Investors are watching closely to see how U.S. political changes could impact Canopy’s expansion plans.

[Read More] Here Is How The Cannabis Industry Impacts The Public Sector

Village Farms International Inc. (VFF)

Village Farms International began as a greenhouse vegetable grower. It later pivoted into cannabis production through its Pure Sunfarms subsidiary. The company now operates as a vertically integrated cannabis and produce business. While Village Farms doesn’t yet own dispensaries in the U.S., it maintains agricultural operations in Texas and has plans for wellness-based expansion.

Pure Sunfarms is one of Canada’s most profitable cannabis producers. It is known for its cost efficiency and strong margins. Village Farms leverages its farming expertise to scale its cannabis operations. The company’s ability to manage multiple product lines gives it a unique position in the market.

On May 12, 2025, Village Farms reported its Q1 2025 earnings. Consolidated revenue came in at $77.1 million. This was slightly down from the $78.1 million posted a year earlier. However, its Canadian cannabis segment delivered a net income of $3 million. This was a 258% increase compared to the prior year.

Adjusted EBITDA for that segment grew by 64% to $6.7 million. These results highlight the strength of the company’s cannabis operations. Meanwhile, the produce segment continues to face weather-related challenges. To address this, Village Farms announced plans to privatize part of its produce business. This move allows the company to focus resources on higher-growth cannabis operations. Investors are optimistic that this shift will unlock more value in the quarters ahead.

Top Canadian Pot Stocks to Buy Before U.S. Federal Reform

Canadian cannabis companies are no longer just domestic players. Each of these three stocks—Tilray, Canopy, and Village Farms—offers a unique path into the growing U.S. market. They are actively restructuring operations, improving balance sheets, and expanding strategic footprints.

Tilray leads with beverages and CPG products. Canopy is leveraging brand strength and U.S. subsidiaries. Village Farms stands out with operational efficiency and profitability. All three companies have shown improvements in key financial metrics this year.

Still, cannabis remains a volatile sector. News, politics, and regulations can move these stocks quickly. As always, traders should use technical analysis and risk management strategies. Identify trend direction, volume changes, and support levels before making entries. Use stop losses to protect capital. Stay informed, stay flexible, and keep an eye on these leaders as the cannabis market heats up in 2025.

The post Best Canadian Marijuana Stocks for U.S. Market Exposure appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..